{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:50:11Z","timestamp":1761094211625,"version":"build-2065373602"},"reference-count":38,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.bbmt.2019.07.009","type":"journal-article","created":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T02:08:47Z","timestamp":1562897327000},"page":"2172-2180","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Drugs as a Frequent Cause of Acute Rash in Patients after CD34+-Selected Peripheral Blood Stem Cell Transplantation"],"prefix":"10.1016","volume":"25","author":[{"given":"Skylar","family":"Klager","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario E.","family":"Lacouture","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2953-0449","authenticated-orcid":false,"given":"Margaret","family":"Hannum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean M.","family":"Devlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Molly","family":"Maloy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0606-9186","authenticated-orcid":false,"given":"Melissa","family":"Pulitzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann A.","family":"Jakubowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alina","family":"Markova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2019.07.009_bib0001","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.bbmt.2016.12.633","volume":"23","author":"Barba","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.07.009_bib0002","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.jaad.2010.07.042","article-title":"Clinical differentiation of acute cutaneous graft-versus-host disease from drug hypersensitivity reactions","volume":"65","author":"Byun","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.bbmt.2019.07.009_bib0003","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/S0140-6736(09)60237-3","article-title":"Graft-versus-host disease","volume":"373","author":"Ferrara","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.bbmt.2019.07.009_bib0004","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s40257-017-0306-9","article-title":"Cutaneous graft-versus-host disease: diagnosis and treatment","volume":"19","author":"Strong Rodrigues","year":"2018","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.bbmt.2019.07.009_bib0005","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/DAD.0000000000000357","article-title":"Histopathologic features of cutaneous acute graft-versus-host disease in T-cell-depleted peripheral blood stem cell transplant recipients","volume":"37","author":"Fischer","year":"2015","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.bbmt.2019.07.009_bib0006","doi-asserted-by":"crossref","first-page":"33","DOI":"10.5826\/dpc.0101a09","article-title":"Histopathology of drug eruptions - general criteria, common patterns, and differential diagnosis","volume":"1","author":"Weyers","year":"2011","journal-title":"Dermatol Pract Concept"},{"key":"10.1016\/j.bbmt.2019.07.009_bib0007","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1001\/archderm.137.1.75","article-title":"The \"drug vs graft-vs-host disease\" conundrum gets tougher, but there is an answer: the challenge to dermatologists","volume":"137","author":"Nghiem","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.bbmt.2019.07.009_bib0008","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1097\/00000478-199709000-00002","article-title":"Value of skin biopsies in assessing prognosis and progression of acute graft-versus-host disease","volume":"21","author":"Kohler","year":"1997","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.bbmt.2019.07.009_bib0009","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/DAD.0b013e3181a85293","article-title":"Quantitative analysis of eosinophils in acute graft-versus-host disease compared with drug hypersensitivity reactions","volume":"32","author":"Weaver","year":"2010","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.bbmt.2019.07.009_bib0010","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1001\/archderm.136.6.717","article-title":"Clinical significance of skin biopsies in the diagnosis and management of graft-vs-host disease in early postallogeneic bone marrow transplantation","volume":"136","author":"Zhou","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.bbmt.2019.07.009_bib0011","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.jaad.2013.01.032","article-title":"DRESS syndrome: Part I. Clinical perspectives","volume":"68","author":"Husain","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.bbmt.2019.07.009_bib0012","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.07.009_bib0013","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1097\/00007890-200212270-00028","article-title":"Hypereosinophilia as a presenting sign of acute graft-versus-host disease after allogeneic bone marrow transplantation","volume":"74","author":"McNeel","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2019.07.009_bib0014","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000155224","article-title":"Severe eosinophilia as a manifestation of acute graft-versus-host disease","volume":"75","author":"Paralkar","year":"2008","journal-title":"Oncology"},{"key":"10.1016\/j.bbmt.2019.07.009_bib0015","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.bbmt.2009.03.009","article-title":"Longitudinal assessment of morbidity and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation: retrospective analysis of a multicenter phase III study","volume":"15","author":"Carnevale-Schianca","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.07.009_bib0016","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1182\/blood-2014-01-552984","article-title":"Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation","volume":"123","author":"Armand","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.07.009_bib0017","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.bbmt.2011.08.017","article-title":"Characteristics of CliniMACS\u00ae System CD34-enriched T cell-depleted grafts in a multicenter trial for acute myeloid leukemia: Blood and Marrow Transplant Clinical Trials Network (BMT CTN) protocol 0303","volume":"18","author":"Keever-Taylor","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.07.009_bib0018","doi-asserted-by":"crossref","first-page":"4552","DOI":"10.1182\/blood-2007-06-093880","article-title":"T cell depleted stem-cell transplantation for adults with hematologic malignancies: sustained engraftment of HLA-matched related donor grafts without the use of antithymocyte globulin","volume":"110","author":"Jakubowski","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.07.009_bib0019","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1046\/j.1365-2141.1997.1112925.x","article-title":"IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade","volume":"97","author":"Rowlings","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2019.07.009_bib0020","first-page":"825","article-title":"1994 Consensus Conference on Acute GVHD Grading","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.07.009_bib0021","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S0190-9622(03)02098-X","article-title":"Lack of specificity in skin biopsy specimens to assess for acute graft-versus-host disease in initial 3 weeks after bone-marrow transplantation","volume":"49","author":"Kuykendall","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.bbmt.2019.07.009_bib0022","doi-asserted-by":"crossref","first-page":"3967","DOI":"10.1182\/blood.V89.11.3967","article-title":"Rapid engraftment without significant graft-versus-host disease after allogeneic transplantation of CD34+-selected cells from peripheral blood","volume":"89","author":"Urbano-Ispizua","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.07.009_bib0023","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1182\/blood-2018-02-791509","article-title":"Biomarkers for post-transplantation outcomes","volume":"131","author":"Paczesny","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.07.009_bib0024","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1182\/blood-2011-06-364265","article-title":"Risk factors for acute GVHD and survival after hematopoietic cell transplantation","volume":"119","author":"Jagasia","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.07.009_bib0025","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1365-2141.1986.tb05545.x","article-title":"Female marrow donors increase the risk of acute graft-versus-host disease: effect of donor age and parity and analysis of cell subpopulations in the donor marrow inoculum","volume":"63","author":"Atkinson","year":"1986","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2019.07.009_bib0026","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1046\/j.1365-2559.2003.01591.x","article-title":"Differential diagnosis of skin lesions after allogeneic haematopoietic stem cell transplantation","volume":"42","author":"Canninga-van Dijk","year":"2003","journal-title":"Histopathology"},{"key":"10.1016\/j.bbmt.2019.07.009_bib0027","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1001\/jama.1986.03380240052027","article-title":"Drug-induced cutaneous reactions. A report from the Boston Collaborative Drug Surveillance Program on 15,438 consecutive inpatients, 1975 to 1982","volume":"256","author":"Bigby","year":"1986","journal-title":"JAMA"},{"key":"10.1016\/j.bbmt.2019.07.009_bib0028","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/bmt.2012.218","article-title":"Toxic erythema of chemotherapy following i.v. BU plus fludarabine for allogeneic PBSC transplant","volume":"48","author":"Parker","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.07.009_bib0029","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.jaad.2008.05.018","article-title":"Toxic erythema of chemotherapy: a useful clinical term","volume":"59","author":"Bolognia","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.bbmt.2019.07.009_bib0030","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/archdermatol.2008.548","article-title":"Palifermin-associated papular eruption","volume":"145","author":"King","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.bbmt.2019.07.009_bib0031","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.jaad.2018.08.044","article-title":"Association between itch and cancer in 16,925 pruritus patients: experience at a tertiary care center","volume":"80","author":"Larson","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.bbmt.2019.07.009_bib0032","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.jaad.2004.02.019","article-title":"Tissue eosinophils and the perils of using skin biopsy specimens to distinguish between drug hypersensitivity and cutaneous graft-versus-host disease","volume":"51","author":"Marra","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.bbmt.2019.07.009_bib0033","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/bmt.2009.135","article-title":"Eosinophilia predicts better overall survival after acute graft-versus-host-disease","volume":"45","author":"Imahashi","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.07.009_bib0034","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/cup.12427","article-title":"Acute cutaneous graft-vs.-host disease compared to drug hypersensitivity reaction with vacuolar interface changes: a blinded study of microscopic and immunohistochemical features","volume":"42","author":"Lehman","year":"2015","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.bbmt.2019.07.009_bib0035","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1159\/000113941","article-title":"Cutaneous graft-versus-host disease: a guide for the dermatologist","volume":"216","author":"H\u00e4usermann","year":"2008","journal-title":"Dermatology"},{"key":"10.1016\/j.bbmt.2019.07.009_bib0036","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1038\/jid.2014.489","article-title":"Epidermal elafin expression is an indicator of poor prognosis in cutaneous graft-versus-host disease","volume":"135","author":"Br\u00fcggen","year":"2015","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.bbmt.2019.07.009_bib0037","doi-asserted-by":"crossref","first-page":"13ra2","DOI":"10.1126\/scitranslmed.3000406","article-title":"Elafin is a biomarker of graft-versus-host disease of the skin","volume":"2","author":"Paczesny","year":"2010","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.bbmt.2019.07.009_bib0038","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.jaad.2018.10.039","article-title":"Markers of systemic involvement and death in hospitalized cancer patients with severe cutaneous adverse reactions","volume":"80","author":"Mori","year":"2019","journal-title":"J Am Acad Dermatol"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879119304410?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879119304410?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:07:15Z","timestamp":1761059235000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879119304410"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":38,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S1083879119304410"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2019.07.009","relation":{},"ISSN":["1083-8791"],"issn-type":[{"type":"print","value":"1083-8791"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drugs as a Frequent Cause of Acute Rash in Patients after CD34+-Selected Peripheral Blood Stem Cell Transplantation","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2019.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}